Synthesis, characterization, and in vivo evaluation of poly(ethylene oxide-co-glycidol)-platinate conjugate.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  European Journal of Pharmaceutical Sciences

• Publication date

  2010-11-20

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejps.2010.07.014PMID 20709170
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amino Functional Poly(ethylene glycol) Copolymers via Protected Amino Glycidol

  2010cited by this paper
• Hetero-Multifunctional Poly(ethylene glycol) Copolymers with Multiple Hydroxyl Groups and a Single Terminal Functionality.

  2010cited by this paper
• Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.

  2009cited by this paper
• PEG conjugates in clinical development or use as anticancer agents: an overview.

  2009cited by this paper
• Synthesis of linear polyether polyol derivatives as new materials for bioconjugation.

  2009cited by this paper
• Synthesis and Evaluation of Pegylated Dendrimeric Nanocarrier for Pulmonary Delivery of Low Molecular Weight Heparin

  2009cited by this paper
• Star-shaped polymers having PEO arms

  2009cited by this paper
• Phase I trial of PEG-interferon and recombinant IL-2 in patients with metastatic renal cell carcinoma

  2008cited by this paper
• Clinical and Pharmacologic Study of the Novel Prodrug Delimotecan (MEN 4901/T-0128) in Patients with Solid Tumors

  2008cited by this paper
• Clinical trial: peg‐interferon alfa‐2b and ribavirin for the treatment of genotype‐1 hepatitis C recurrence after liver transplantation

  2008cited by this paper
• Phase I and pharmacokinetic trial of AP5346, a DACH–platinum–polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patients

  2007cited by this paper
• Synthesis of amphiphilic copolymer brushes: Poly(ethylene oxide)‐graft‐polystyrene

  2006cited by this paper
• Poly(gamma,L-glutamic acid)-cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice.

  2006cited by this paper
• Polymer therapeutics for cancer : Current status and future challenges

  2006cited by this paper
• Biocompatibility testing of branched and linear polyglycidol.

  2006cited by this paper
• Toward an easy access to dendrimer-like poly(ethylene oxide)s.

  2005cited by this paper
• Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase

  2005cited by this paper
• Recent Advances in Chemistry and Applications of Substituted Poly(ethylene glycol)s

  2005cited by this paper
• Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review

  2004cited by this paper
• Blood levels and serum protein binding of cis-Platinum(II) complexed to carboxymethyl-dextran

  2004cited by this paper
• Phase I and pharmacokinetic (PK) study of MAG-CPT (PNU 166148): a polymeric derivative of camptothecin (CPT)

  2004cited by this paper
• A Phase I and Pharmacological Study of the Platinum Polymer AP5280 Given as an Intravenous Infusion Once Every 3 Weeks in Patients with Solid Tumors

  2004cited by this paper
• Improved targeting of platinum chemotherapeutics. the antitumour activity of the HPMA copolymer platinum agent AP5280 in murine tumour models.

  2004cited by this paper
• Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival.

  2003cited by this paper
• Synthesis, characterization and preliminary cytotoxicity assays of poly(ethylene glycol)-malonato-Pt-DACH conjugates.

  2003cited by this paper
• A phase I and pharmacokinetic study of pegylated camptothecin as a 1-hour infusion every 3 weeks in patients with advanced solid malignancies.

  2003cited by this paper
• Nasopharyngeal carcinoma.

  2002cited by this paper
• HPMA Copolymers Platinates Containing Dicarboxylato Ligands. Preparation, Characterisation and In Vitro and In Vivo Evaluation

  2002cited by this paper
• High molecular weight functionalized poly(ethylene oxide)

  2002cited by this paper
• Platinum complexes for the treatment of cancer

  2001cited by this paper
• Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel

  2001cited by this paper
• Design of poly(ethylene glycol) immobilizing platinum complex through chelate-type coordination bond

  2000cited by this paper
• Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

  2000cited by this paper
• HPMA copolymer platinates as novel antitumour agents: in vitro properties, pharmacokinetics and antitumour activity in vivo.

  1999cited by this paper
• Tumor accumulation of poly(ethylene glycol) with different molecular weights after intravenous injection

  1997cited by this paper
• Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier.

  1995cited by this paper
• Drug accumulation and DNA platination in cells exposed to aquated cisplatin species.

  1994cited by this paper
• Pharmacokinetics in design of polymeric drug delivery systems

  1994cited by this paper
• Copolymers of lysine and polyethylene glycol: a new family of functionalized drug carriers.

  1993cited by this paper
• Copolymers of lysine and polyethylene glycol: a new family of functionalized drug carriers

  1993cited by this paper
• Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD)

  1993cited by this paper
• SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.

  1991cited by this paper
• Nasopharyngeal Carcinoma

  1966cited by this paper

• Nanomedicines for Delivery of Cytarabine: Effect of Carrier Structure and Spacer on the Anti-Lymphoma Efficacy

  2025cites this paper
• Hydrophilic Polyethers Derived from Functional Epoxides: Beyond Poly(ethylene glycol)

  2025cites this paper
• Coordinative Double Hydrophilic All-Polyether Micelles for pH-Responsive Delivery of Cisplatin.

  2024cites this paper
• The assembly and antitumor activity of lycium barbarum polysaccharide-platinum-based conjugates.

  2020cites this paper
• Hydroxyethyl starch and its derivatives as nanocarriers for delivery of diagnostic and therapeutic agents towards cancers

  2020cites this paper
• Nanomedicines for improved targetability to inflamed synovium for treatment of rheumatoid arthritis: Multi-functionalization as an emerging strategy to optimize therapeutic efficacy.

  2019cites this paper
• Polysaccharide nanoconjugates for drug solubilization and targeted delivery

  2019cites this paper
• Functional polymers: an introduction in the context of biomedical engineering

  2019cites this paper
• Clinical developments of antitumor polymer therapeutics

  2019cites this paper
• DESIGN AND DEVELOPMENT OF REDOX-RESPONSIVE NANOCARRIERS FOR THERAPEUTIC DELIVERY

  2018cites this paper
• De Novo Synthesis of Phosphorylated Triblock Copolymers with Pathogen Virulence-Suppressing Properties That Prevent Infection-Related Mortality.

  2017cites this paper
• Nano-sized solid dispersions based on hydrophobic-hydrophilic conjugates for dissolution enhancement of poorly water-soluble drugs.

  2017cites this paper
• Conventional Oxyanionic versus Monomer-Activated Anionic Copolymerization of Ethylene Oxide with Glycidyl Ethers: Striking Differences in Reactivity Ratios.

  2016cites this paper
• Polymeric Prodrugs Containing Metal-Based Anticancer Drugs

  2015cites this paper
• Polymers with complicated architectures constructed from the versatile, functional monomer 1-ethoxyethyl glycidyl ether

  2015cites this paper
• Conjugation of curcumin onto alginate enhances aqueous solubility and stability of curcumin.

  2014cites this paper
• Polymer-Based Drug Delivery Systems for Solid Tumor Treatment

  2014cites this paper
• Formadores de filmes híbridos orgânicos inorgânicos do tipo ureasil-poliéter para liberação controlada de fármacos

  2012cites this paper
• Functional PEG-based polymers with reactive groups via anionic ROP of tailor-made epoxides

  2012cites this paper
• N,N-Diallylglycidylamine: A Key Monomer for Amino-Functional Poly(ethylene glycol) Architectures

  2012cites this paper
• Polymeric nanoparticles with encapsulated superparamagnetic iron oxide and conjugated cisplatin for potential bladder cancer therapy.

  2012cites this paper
• Polymeric conjugates for drug delivery.

  2012cites this paper
• A poly(γ, L-glutamic acid)-citric acid based nanoconjugate for cisplatin delivery.

  2012cites this paper
• Cell death in HeLa mediated by thermoplastic polyurethane with co-immobilized IFN-γ plus TNF-α.

  2012cites this paper
• Synthesis and characterization of carboxylic acid conjugated, hydrophobically derivatized, hyperbranched polyglycerols as nanoparticulate drug carriers for cisplatin.

  2011cites this paper
• Multifunctional Poly(ethylene glycol)s.

  2011cites this paper
• Multifunktionelle Poly(ethylenglycole)

  2011cites this paper